60
Participants
Start Date
December 31, 2016
Primary Completion Date
October 24, 2017
Study Completion Date
January 24, 2018
Vadadustat
Daily oral dose
Placebo
Daily oral dose
Aichi
Ehime
Fukui
Hiroshima
Hokkaido
Hyōgo
Ibaraki
Kagoshima
Kochi
Miyagi
Nagano
Nagasaki
Niigata
Okinawa
Osaka
Ōita
Saitama
Shizuoka
Lead Sponsor
Akebia Therapeutics
INDUSTRY